T Cell Vaccination Benefits Relapsing Progressive Multiple Sclerosis Patients: A Randomized, Double-Blind Clinical Trial

BACKGROUND: T-cell vaccination (TCV) for multiple sclerosis (MS) refers to treatment with autologous anti-myelin T-cells, attenuated by irradiation. Previously published clinical trials have been all open-labeled. AIM: To evaluate the safety and efficacy of TCV in progressive MS, in a double-blind,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Karussis, Dimitrios, Shor, Hagai, Yachnin, Julia, Lanxner, Naama, Amiel, Merav, Baruch, Keren, Keren-Zur, Yael, Haviv, Ofra, Filippi, Massimo, Petrou, Panayiota, Hajag, Shalom, Vourka-Karussis, Urania, Vaknin-Dembinsky, Adi, Khoury, Salim, Abramsky, Oded, Atlan, Henri, Cohen, Irun R., Abulafia-Lapid, Rivka
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2012
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3522721/
https://ncbi.nlm.nih.gov/pubmed/23272061
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0050478
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados